Across
- 3. A condition defined by an HbA1c range of 5.7–6.4%, requiring annual repeat testing and lifestyle changes.
- 4. The diagnostic parameter for Fasting Plasma Glucose, which indicates diabetes if the value is less than 126 mg/dL
- 7. A low-cost dual therapy option, such as Glimepiride, often added if glycemic goals are not met with monotherapy
- 8. A microvascular complication requiring a dilated eye examination at the time of diagnosis for all Type 2 patients
- 9. The first-line pharmacological therapy for Type 2 Diabetes, typically started at 500 mg once or twice daily.
- 10. The classification for diabetes first detected during pregnancy, often requiring management if a 2-hour PG is greater than or equal to 140 mg/dL.
Down
- 1. A critical risk associated with certain medications like Glibenclamide, which is no longer preferred as a first-line agent for this reason
- 2. A complication screened using the Urine Albumin-to-Creatinine Ratio (UACR) via a dipstick test at diagnosis.
- 5. The treatment of choice for pregnancy, Type 1 Diabetes, or when Fasting Plasma Glucose is >250 mg/dL with ketonuria.
- 6. Also known as HbA1c, the target for most non-pregnant adults is to keep this value below 7%